Companies /Healthcare

Haleon plc

NYSE: HLN Drug Manufacturers - Specialty & Generic
$8.80
▲ $0.08 (+0.92%) today
Markets closed · 8:46am ET

24/7 Wall St. View

Fundamentals

Market Cap
$38.7B
P/E Ratio
18.3
Dividend Yield
2.25%
Profit Margin
14.5%
Revenue (TTM)
$11.2B
EPS (TTM)
$0.48
52-Week Range
$9 – $11
Street Target
$11.93

About Haleon

Haleon plc is a leading global healthcare company based in the United Kingdom, specializing in a wide range of consumer health products. Its offerings include oral health items, pain relievers, respiratory and digestive health products, as well as vitamins, minerals, and supplements. Haleon is known for its popular brands such as Advil, Sensodyne, Panadol, and Centrum, among others. Established in 2021 and originally named DRVW 2022 plc, Haleon has quickly become a household name in healthcare, serving customers across North America, Europe, and Asia Pacific.

HLN Coverage